Glucosamine therapy compared to ibuprofen for joint pain.

To determine the effectiveness of oral glucosamine with ibuprofen for the relief of joint pain in osteoarthritis a mini-review (Griffiths, 2002) of double-blind randomized controlled trials comparing the two was undertaken. The population was adult patients diagnosed with osteoarthritis at any site. The outcome was arthritic pain reduction. Searches on Medline, Embase, AMED, the Cochrane Library and the Merck index identified four trials. Of these, two studies were obtainable and were included in the review. Both compared 1.2 g ibuprofen daily with 1.5 g glucosamine sulphate daily, in three divided doses. The combined number of participants in the studies was 218. The results of these studies showed glucosamine to be of similar efficacy to ibuprofen. The conclusion is that glucosamine is effective in relieving joint pain associated with osteoarthritis. Glucosamine's pain-relieving effects may be due to its cartilage-rebuilding properties; these disease-modifying effects are not seen with simple analgesics and are of particular benefit. In practice glucosamine can be used as an alternative to anti-inflammatory drugs and analgesics or as a useful adjunct to standard analgesic therapy.
AuthorsRachael Ruane, Peter Griffiths
JournalBritish journal of community nursing (Br J Community Nurs) Vol. 7 Issue 3 Pg. 148-52 (Mar 2002) ISSN: 1462-4753 [Print] England
PMID11904551 (Publication Type: Comparative Study, Journal Article, Review)
Chemical References
  • Glucosamine
  • Ibuprofen
  • Arthralgia (drug therapy)
  • Glucosamine (therapeutic use)
  • Humans
  • Ibuprofen (therapeutic use)
  • Osteoarthritis (drug therapy)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: